P53 protein plays a key role in tissue repair, study finds 11 February 2022 New research led by the University of Bristol has found the protein p53 plays a key role in epithelial migration and tissue repair. The findings could improve our understanding of the processes used by cells to repair tissues, and be used to identify interventions that could accelerate and improve wound repair.
- CMM Spotlight Series: Dr Asme Boussahel 18 November 2022 As part of our CMM Spotlight Series, PhD students' Dora Bonini and Michaela Gregorova interview Dr Asme Boussahel - a Daphne Jackson Research Fellow in CMM.
- Patient-specific cancer tumours replicated in 3D bioprinting advance 2 November 2022 Bowel cancer patients could in future benefit from a new 3D bioprinting technology which would use their own cells to replicate the complex cellular environment of solid tumours in 3D models. The University of Bristol-led advance, published in Biofabrication, would allow clinicians to treat the models, known as spheroids, with chemotherapy drugs and radiation to help them understand an individual patient’s resistance to therapies.
- P53 protein plays a key role in tissue repair, study finds 11 February 2022 New research led by the University of Bristol has found the protein p53 plays a key role in epithelial migration and tissue repair. The findings could improve our understanding of the processes used by cells to repair tissues, and be used to identify interventions that could accelerate and improve wound repair.
- CMM Spotlight Series: Dr Jon Tyrrell 30 November 2021 Jon Tyrrell is a lecturer in microbiology within CMM. Alongside his teaching, his research focuses on antibiotic resistance and its evolution. He is also the school’s digital champion and co-lead on CMM’s transition to online and blended learning. Public engagement and public-involved research is also a keen interest of his. Continuing our Spotlight Series, PGR students Luis Martinez Robles and Will Gibbs interviewed Dr Tyrrell to find out more about his research, inclusive teaching and developing a work/life balance as a parent.
- CMM Spotlight Series: Dr Isabel Murillo Cabeza 28 October 2021 As part of our CMM Spotlight Series, PhD students' Carissa Wong and Michaela Gregorova interview CMM Lecturer in Microbiology Dr Isabel Murillo Cabeza to discuss her own journey into science, along with her thoughts on how we can change the scientific culture for women right now.
- Celebrating Postdoc Appreciation Week 2021 22 September 2021 It is Postdoc Appreciation Week from 20-24 September 2021 and the School of Cellular and Molecular Medicine would like to celebrate and recognise the hard work and achievements of our postdoctoral community.
- CMM Spotlight Series: Professor Anne Ridley 10 August 2021 Continuing our CMM Spotlight Series, PhD students' Carissa Wong and Michaela Gregorova turn the lens on Women in STEM, interviewing Professor Anne Ridley FRS FRSB FMedSci FRMS - Professor of Cell Biology and Head of School here at CMM. Her research has made seminal contributions to our understanding of cancer progression and inflammation through her work on cell migration. Her work initiated a whole research field studying the function and regulation of Rho GTPases, and has influenced many areas of medical research, from cancer metastasis to cardiovascular and infectious diseases.
- Congratulations to our 2021 graduating students! 28 July 2021 We were delighted to throw a 'Virtual Celebration' for our graduating students of 2021 in lieu of an in-person event this year.
- CMM Spotlight Series: Dr Bethan Lloyd-Lewis 28 June 2021 As part of our CMM Spotlight Series, PhD students' Drinalda Cela and Michaela Gregorova interview Dr Bethan Lloyd-Lewis - a Vice Chancellor's Fellow in CMM. Her research is focused on examining the biological mechanisms that regulate epithelial cell fate during tissue development and the early stages of cancer, with a particular interest in breast biology. The aim of her research is ultimately to define improved approaches for breast cancer prevention and early detection, in addition to informing the development of new chemo-preventative and therapeutic strategies.
- Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy 24 June 2021 An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.